期刊文献+

我院2007年至2009年口服降糖药应用分析 被引量:3

Application Analysis on Oral Hypoglycemic Agents in Our Hospital during 2007-2009
下载PDF
导出
摘要 目的分析医院口服降糖药的应用情况及趋势,为临床合理用药提供参考。方法采用限定日剂量方法,对医院2007年至2009年口服降糖药的销售金额、用药频度等进行统计分析。结果口服降糖药销售金额及所占比例呈逐年上升趋势,其中胰岛素增敏剂增幅较大,促胰岛素分泌剂和α-葡萄糖苷酶抑制剂上升趋缓。结论该院口服降糖药结构调整明显,胰岛素增敏剂有增长过快的趋势。 Objective To analyze the status and trends of oral hypoglycemic agents application to provide reference for rational drug use in clinic.Methods The defined daily dose(DDD) method was adopted to perform the statistical analysis in aspects of the amount of oral hypoglycemic agents,its proportion of sales and DDDs in our hospital during 2007 —2009.Results The amount and percentage of sales in oral hypoglycemic agents showed the increasing trend year by year.Among them,the amount of insulin sensitizer had larger increment amplitude,while the upinsulin secretagogues and α-glucosidase inhibitors rose to slow down.Conclusion The structure regulation of oral hypoglycemic agents in our hospital is obvious and insulin sensitizers reveals the trend of excessive growth.
作者 李果
机构地区 重庆长安医院
出处 《中国药业》 CAS 2011年第18期51-52,共2页 China Pharmaceuticals
关键词 口服降糖药 限定日剂量 用药频度 用药分析 oral hypoglycemic agents DDD DDDs drug use analysis
  • 相关文献

参考文献3

  • 1中国医学会糖尿病学会.中国糖尿病防治指南[M].北京:北京大学医学出版社.2004:10.
  • 2中国医师药师临床用药指南/卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版社.2009:4.
  • 3张俊清,郭晓蕙,洪旭,田慧,朱良香,肖文华,陈颖丽,王力,陈宇,安良,杜锦,袁申元,邓正照,卢纹凯,曹雪霞,高妍.格列美脲治疗2型糖尿病安全性和有效性的多中心临床研究[J].中国临床药理学杂志,2003,19(6):409-412. 被引量:14

二级参考文献4

  • 1[1]Muller G, Hartz D, Punter J, et al. Differential interaction of glimepiride and glibenclamide with the β -cell sulfonylurea receptor Ⅰ. Binding charatteristics[J]. Biochim Biophys Acta,1994; 1191:267-277.
  • 2[2]Kramer W, Muller G, Girbig F, et al. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor Ⅱ. Photoaffinity labeling of a 65 kDa protein by [3H] glimepiride[J]. Biochim Biophys Acta, 994;1191:278-290.
  • 3[3]Sonnenberg GE, Garg DC, Weidler DJ, et al. Short-terrn comparison of once-versus twice-daily administration of glimepiride in patient with non-insulin-dependent diabetes mellitus[J]. Am Pharmacother,1997;31:671-676.
  • 4[4]Muller G, Geisen K. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes[J]. Horm Metab Res, 1996;28:468-487.

共引文献14

同被引文献24

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部